Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4,5 Dehydrogentamicin
2. 4,5-dehydrogentamicin
3. Antibiotic 6640
4. Extramycin
5. Pathomycin
6. Rickamicin
7. Sch 13475
8. Sch-13475
9. Sch13475
10. Siseptin
11. Sisomicin Sulfate
12. Sisomicin Sulfate (2:5) Salt
13. Sisomycin
14. Sissomicin
15. Sizomycin
1. Rickamicin
2. Sisomycin
3. 32385-11-8
4. Sissomicin
5. Antibiotic 6640
6. Antibiotic 66-40
7. Sch 13475
8. Dehydrogentamicin Cla
9. Sch-13475
10. X55xsl74yq
11. Chebi:9169
12. Sisomin
13. D-streptamine, O-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-
14. Sisomicinum
15. Sisomicina
16. Sisomicine
17. (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
18. Sisomicine [inn-french]
19. Sisomicinum [inn-latin]
20. Salvamina
21. Sisomicina [inn-spanish]
22. Siseptin Sulfate
23. (1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yloxy]-2-hydroxycyclohexyl 3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranoside
24. (1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranoside
25. (2r,3r,4r,5r)-2-(((1s,2s,3r,4s,6r)-4,6-diamino-3-(((2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2h-pyran-3,5-diol
26. O-2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6))-2-deoxy-d-streptamine
27. Einecs 251-018-2
28. Unii-x55xsl74yq
29. Brn 1357913
30. Sisomicin [usan:inn:ban]
31. Sch13475
32. Sisomicin-sulfate
33. Sis
34. Siso
35. Sisomicin [inn]
36. Sisomicin [mi]
37. Sisomicin (usan/inn)
38. Sisomicin [usan]
39. Sisomicin [who-dd]
40. Schembl49395
41. O-2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6)-2-deoxy-d-streptamine
42. O-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1-6))-2-deoxy-l-streptamine
43. Chembl221886
44. Gtpl10858
45. (2s-cis)-4-o-(3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl)-2-deoxy-6-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl)-d-streptamine
46. Zinc56870809
47. Akos015895179
48. Db12604
49. (2s-cis)-4-o-(3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl)-2-deoxy-6-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl)-d-streptamine
50. 85s118
51. C00494
52. D02544
53. Gentamicin Sulfate Impurity A [ep Impurity]
54. Q3962119
55. (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3,5-diol
56. (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
57. 2-deoxy-4-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl)-6-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-glycero-hex-4-enopyranosyl)-l-streptamine
58. O-3-deoxy-4-c-methyl-3-(methylamino)-.beta-l-arabinopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-l-streptamine
| Molecular Weight | 447.5 g/mol |
|---|---|
| Molecular Formula | C19H37N5O7 |
| XLogP3 | -5.1 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 6 |
| Exact Mass | 447.26929854 g/mol |
| Monoisotopic Mass | 447.26929854 g/mol |
| Topological Polar Surface Area | 214 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 643 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01G - Aminoglycoside antibacterials
J01GB - Other aminoglycosides
J01GB08 - Sisomicin
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sisomicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sisomicin, including repackagers and relabelers. The FDA regulates Sisomicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sisomicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sisomicin supplier is an individual or a company that provides Sisomicin active pharmaceutical ingredient (API) or Sisomicin finished formulations upon request. The Sisomicin suppliers may include Sisomicin API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sisomicin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sisomicin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sisomicin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sisomicin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sisomicin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sisomicin suppliers with NDC on PharmaCompass.
Sisomicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sisomicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sisomicin GMP manufacturer or Sisomicin GMP API supplier for your needs.
A Sisomicin CoA (Certificate of Analysis) is a formal document that attests to Sisomicin's compliance with Sisomicin specifications and serves as a tool for batch-level quality control.
Sisomicin CoA mostly includes findings from lab analyses of a specific batch. For each Sisomicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sisomicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Sisomicin EP), Sisomicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sisomicin USP).
LOOKING FOR A SUPPLIER?
